首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Advanced drug delivery reviews

缩写:ADV DRUG DELIVER REV

ISSN:0169-409X

e-ISSN:1872-8294

IF/分区:21.0/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引3288条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Johann Gout,Menar Ekizce,Elodie Roger et al. Johann Gout et al.
Pancreatic ductal adenocarcinoma (PDAC) is a lethal solid malignancy, rapidly progressing and highly therapeutic resistant, as reflected by its very low five-year overall survival. Despite significant advancements in our understanding of it...
Hemant Singh,Mahmood Razzaghi,Hamed Ghorbanpoor et al. Hemant Singh et al.
Carbon dots (CDs) are recently introduced carbon nanomaterials showing diverse properties like unique fluorescent behavior, low cost, ecofriendliness, electron mobility, potent antioxidant, antibacterial capabilities, good biocompatibility,...
Giulia Porro,Marco Basile,Zhengdong Xie et al. Giulia Porro et al.
Efficient drug delivery across the blood-brain barrier (BBB) remains a significant obstacle in treating central nervous system (CNS) disorders. This review provides an in-depth analysis of the structural and molecular mechanisms underlying ...
Immacolata Maietta,África González-Fernández,Rosana Simón-Vázquez Immacolata Maietta
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive and often fatal form of malignancy frequently diagnosed at an advanced stage, posing significant challenges for treatment. The complex and intricate microenvironment of PDAC, characte...
Gabriele Coppola,Fabiola Cennamo,Giuseppe Ciccone et al. Gabriele Coppola et al.
The possibility of correcting genetic and epigenetic alterations through gene therapies has been considered a cornerstone in oncology. However, modest results have been achieved in clinics, mainly due to inefficient tumor targeting and side...
Hemant Singh,Muath Tuffaha,Shivi Tripathi et al. Hemant Singh et al.
Drug delivery is a process to deliver the right amount of drug to the right place at the right time, while minimizing possible side effects and maximizing beneficial effectiveness. This is accomplished by drug delivery systems (DDSs), which...
Ekaterina Kolesova,Sabina Pulone,Dmitry Kostyushev et al. Ekaterina Kolesova et al.
This review explores the transformative role of CRISPR/Cas systems in optical bioimaging, emphasizing how advancements in nanoparticle (NP) technologies are revolutionizing the visualization of gene-editing processes both in vitro and in vi...
Dionysis Kampasis,Elisa Uliassi,Maria Laura Bolognesi Dionysis Kampasis
Circadian rhythm disruption (CRD) is a common feature of several brain disorders. The restoration of circadian clock function and the development of circadian-based therapies may have significant therapeutic implications for brain diseases ...
Siqi Li,Mengdi Xu,Chi Yao et al. Siqi Li et al.
DNA nanostructures, with sequence programmability, biocompatibility, and structural versatility, have emerged as promising tools for biomedical applications, particularly in targeted drug delivery and therapeutic interventions. The tumor mi...